Of 15,768 eligible patients with COPD who were hospitalized for pneumonia, 8271 had prior ICS use and 7497 had no ICS use. Compared with patients with no prior ICS use, those with prior ICS use had a lower 90-day mortality rate 17.3% vs 22.8%; P < .001.

via Inhaled Steroids Lower Pneumonia Mortality in COPD Patients.